Suppr超能文献

封锁和 COVID-19 大流行:结局是什么?

Lockdowns and the COVID-19 pandemic: What is the endgame?

机构信息

National Public Health Organisation, Greece.

School of Medicine, European University Cyprus, Cyprus.

出版信息

Scand J Public Health. 2021 Feb;49(1):37-40. doi: 10.1177/1403494820961293. Epub 2020 Sep 26.

Abstract

An overall long-term strategy for managing the coronavirus disease 2019 (COVID-19) pandemic is presented. This strategy will need to be maintained until herd immunity is achieved, hopefully through vaccination rather than natural infection. We suggest that a pure test-trace-isolate strategy is likely not practicable in most countries, and a degree of social distancing, ranging up to full lockdown, is the main public-health tool to mitigate the COVID-19 pandemic. Guided by reliable surveillance data, distancing should be continuously optimised down to the lowest sustainable level that guarantees a low and stable infection rate in order to balance its wide-ranging negative effects on public health. The qualitative mixture of social-distancing measures also needs to be carefully optimised in order to minimise social costs.

摘要

提出了管理 2019 年冠状病毒病(COVID-19)大流行的总体长期策略。在实现群体免疫之前,需要维持这一策略,希望通过疫苗接种而不是自然感染来实现。我们认为,纯粹的检测-追踪-隔离策略在大多数国家可能不可行,社会隔离程度,最高可达全面封锁,是减轻 COVID-19 大流行的主要公共卫生工具。根据可靠的监测数据,应不断优化隔离措施,降至可确保低而稳定的感染率的最低可持续水平,以平衡其对公共卫生的广泛负面影响。还需要仔细优化社会隔离措施的定性组合,以将社会成本降至最低。

相似文献

1
Lockdowns and the COVID-19 pandemic: What is the endgame?
Scand J Public Health. 2021 Feb;49(1):37-40. doi: 10.1177/1403494820961293. Epub 2020 Sep 26.
2
Herd immunity: challenges and the way forward in Korea.
Epidemiol Health. 2021;43:e2021054. doi: 10.4178/epih.e2021054. Epub 2021 Aug 18.
3
COVID-19 exit strategy during vaccine implementation: a balance between social distancing and herd immunity.
Arch Virol. 2022 Sep;167(9):1773-1783. doi: 10.1007/s00705-022-05495-7. Epub 2022 Jun 20.
4
COVID-19 pandemic and vaccination build herd immunity.
Eur Rev Med Pharmacol Sci. 2021 Jan;25(2):577-579. doi: 10.26355/eurrev_202101_24613.
5
Are COVID vaccination programmes working? Scientists seek first clues.
Nature. 2021 Jan;589(7843):504-505. doi: 10.1038/d41586-021-00140-w.
6
When should the UK lift its lockdown?
Lancet Respir Med. 2021 Apr;9(4):e44-e45. doi: 10.1016/S2213-2600(21)00106-5. Epub 2021 Feb 19.
8
Will achieving herd immunity be a road to success to end the COVID-19 pandemic?
J Infect. 2021 Sep;83(3):381-412. doi: 10.1016/j.jinf.2021.06.007. Epub 2021 Jun 10.
10
Impact of vaccination on the COVID-19 pandemic in U.S. states.
Sci Rep. 2022 Jan 28;12(1):1554. doi: 10.1038/s41598-022-05498-z.

引用本文的文献

3
Optimal approaches for COVID-19 control: the use of vaccines and lockdowns across societal groups.
Front Epidemiol. 2024 Jul 9;4:1308974. doi: 10.3389/fepid.2024.1308974. eCollection 2024.
4
Management of Psoriasis Patients with Serious Infectious Diseases.
Adv Ther. 2024 Jun;41(6):2099-2111. doi: 10.1007/s12325-024-02873-2. Epub 2024 May 6.
5
Impact of the COVID-19 pandemic on clinical and psychological aspects of temporomandibular disorders.
BMC Oral Health. 2024 Apr 12;24(1):447. doi: 10.1186/s12903-024-04168-y.
6
Meta-analysis of KAP toward COVID-19 in Chinese residents.
Front Public Health. 2024 Mar 1;12:1279293. doi: 10.3389/fpubh.2024.1279293. eCollection 2024.
8
New Onset and Exacerbation of Psoriasis Following COVID-19 Vaccination: A Review of the Current Knowledge.
Biomedicines. 2023 Aug 3;11(8):2191. doi: 10.3390/biomedicines11082191.
9
COVID-19 vaccination in the mass vaccination center: clinical practice and effectiveness analysis.
Front Public Health. 2023 Jun 15;11:1072883. doi: 10.3389/fpubh.2023.1072883. eCollection 2023.
10
Understanding Covid-19 Mobility Through Human Capital: A Unified Causal Framework.
Comput Econ. 2023 Feb 21:1-41. doi: 10.1007/s10614-023-10359-6.

本文引用的文献

1
Individual variation in susceptibility or exposure to SARS-CoV-2 lowers the herd immunity threshold.
J Theor Biol. 2022 May 7;540:111063. doi: 10.1016/j.jtbi.2022.111063. Epub 2022 Feb 18.
2
Infection fatality rate of COVID-19 inferred from seroprevalence data.
Bull World Health Organ. 2021 Jan 1;99(1):19-33F. doi: 10.2471/BLT.20.265892. Epub 2020 Oct 14.
3
A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates.
Int J Infect Dis. 2020 Dec;101:138-148. doi: 10.1016/j.ijid.2020.09.1464. Epub 2020 Sep 29.
4
Diabetic Foot Problems During the COVID-19 Pandemic in a Tertiary Care Center: The Emergency Among the Emergencies.
Diabetes Care. 2020 Oct;43(10):e123-e124. doi: 10.2337/dc20-1347. Epub 2020 Jul 23.
5
SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection.
Sci Immunol. 2020 Jul 17;5(49). doi: 10.1126/sciimmunol.abd6160.
6
Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study.
Lancet Infect Dis. 2020 Oct;20(10):1141-1150. doi: 10.1016/S1473-3099(20)30471-0. Epub 2020 Jun 17.
7
Rethinking the role of the school after COVID-19.
Lancet Public Health. 2020 Jul;5(7):e370. doi: 10.1016/S2468-2667(20)30124-9. Epub 2020 May 25.
9
A strategic approach to COVID-19 vaccine R&D.
Science. 2020 May 29;368(6494):948-950. doi: 10.1126/science.abc5312. Epub 2020 May 11.
10
Changes in contact patterns shape the dynamics of the COVID-19 outbreak in China.
Science. 2020 Jun 26;368(6498):1481-1486. doi: 10.1126/science.abb8001. Epub 2020 Apr 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验